Drugs for Pulmonary Hypertension — MCQs
Drug not used in pulmonary hypertension is:
Which of the following diseases is appropriately treated with combined heart-lung transplantation?
Which of the following statements about Tadalafil is incorrect?
Which of the following is not a recognized use of alpha-2-agonists?
Which class of antihypertensive drugs is known to cause erectile dysfunction?
Which of the following is the best inotrope agent for use in right heart failure secondary to pulmonary hypertension?
Which of the following medications is not typically used for the treatment of erectile dysfunction?
Drug of choice for Liddle syndrome
A female has a systolic blood pressure of 130 mmHg and a diastolic blood pressure of 100 mmHg on two consecutive occasions, indicating Stage 2 hypertension. What is the best treatment?
A 27-year-old intravenous drug user presents with difficulty swallowing. Examination of the oropharynx reveals white plaques along the tongue and the oral mucosa. Which of the following best describes the microscopic appearance of the microorganism responsible for this patient's illness?
Drugs for Pulmonary Hypertension Indian Medical PG Practice Questions and MCQs
Question 1: Drug not used in pulmonary hypertension is:
- A. Endothelin receptor antagonist
- B. Prostacyclin
- C. Alpha blocker (Correct Answer)
- D. Calcium channel blocker
Explanation: ***Alpha blocker*** - Alpha-blockers primarily cause **systemic vasodilation** [1] and are not indicated for the specific pulmonary vascular remodeling and vasoconstriction seen in pulmonary hypertension. [2] - Their use could lead to an undesirable drop in **systemic blood pressure** [3] without adequately addressing the pulmonary arterial pressure. *Calcium channel blocker* - **Calcium channel blockers** (namely **dihydropyridines** like nifedipine and amlodipine) are used in a small subset of pulmonary hypertension patients who are **vasoreactive** on acute testing. - They work by relaxing pulmonary arterial smooth muscle, reducing **pulmonary vascular resistance**. *Endothelin receptor antagonist* - **Endothelin receptor antagonists** (e.g., bosentan, ambrisentan) block the effects of **endothelin-1**, a potent vasoconstrictor and smooth muscle proliferator involved in pulmonary hypertension. - They improve hemodynamics, exercise capacity, and clinical outcomes by preventing **vasoconstriction** and **vascular remodeling**. *Prostacyclin* - **Prostacyclin analogs** (e.g., epoprostenol, treprostinil) are potent **vasodilators** and inhibitors of platelet aggregation. - They are highly effective in treating severe pulmonary hypertension by relaxing pulmonary arteries and preventing **thrombosis**.
Question 2: Which of the following diseases is appropriately treated with combined heart-lung transplantation?
- A. End-stage emphysema
- B. Idiopathic dilated cardiomyopathy with long-standing secondary pulmonary hypertension (Correct Answer)
- C. Primary pulmonary hypertension
- D. Cystic fibrosis
Explanation: ***Idiopathic dilated cardiomyopathy with long-standing secondary pulmonary hypertension*** - In cases of severe **idiopathic dilated cardiomyopathy**, the failing left ventricle can lead to **long-standing secondary pulmonary hypertension**. - This persistent high pressure in the pulmonary circulation results in **irreversible damage** to the pulmonary vasculature, creating fixed pulmonary vascular resistance. - When the pulmonary hypertension becomes fixed and irreversible, isolated heart transplantation would fail as the new heart would face the same elevated pressures, necessitating **combined heart-lung transplantation**. *End-stage emphysema* - **End-stage emphysema** primarily affects the lungs, causing destruction of alveolar walls and airflow obstruction. - While a **bilateral lung transplant** is the standard treatment for severe emphysema, the heart is typically not primarily affected to the extent that it would require combined transplantation. *Primary pulmonary hypertension* - **Primary pulmonary hypertension** is a disease of the pulmonary arteries, where blood vessels in the lungs become narrowed, stiff, or destroyed. - In most cases, **bilateral lung transplantation** alone is sufficient, as the new lungs provide healthy pulmonary vasculature. - While combined heart-lung transplantation may be considered in severe cases with established irreversible right ventricular failure, the more definitive indication is when secondary pulmonary hypertension is caused by primary cardiac disease (as in option A). *Cystic fibrosis* - **Cystic fibrosis** is a genetic disorder that predominantly causes severe lung disease due to thick, sticky mucus buildup. - It primarily necessitates a **bilateral lung transplant** to replace the diseased lungs; the heart is generally not directly affected to the point of requiring a combined transplant.
Question 3: Which of the following statements about Tadalafil is incorrect?
- A. Its half life is 17.5 hours
- B. It is used in erectile dysfunction
- C. It is longest acting phosphodiesterase inhibitor
- D. It cannot be used for the treatment of PAH (Correct Answer)
Explanation: ***It cannot be used for the treatment of PAH*** - This statement is incorrect because **Tadalafil** (Adcirca®) is, in fact, approved and commonly used for the treatment of **pulmonary arterial hypertension (PAH)**, as it causes vasodilatation in the pulmonary vasculature. - It works by inhibiting phosphodiesterase-5 (PDE5), leading to increased **cGMP** levels and smooth muscle relaxation in the pulmonary arteries. *It is longest acting phosphodiesterase inhibitor* - This statement is correct. **Tadalafil** has the longest duration of action among the PDE5 inhibitors, with effects lasting up to 36 hours, hence its nickname "the weekend pill." - This extended duration is due to its longer half-life compared to other PDE5 inhibitors like sildenafil or vardenafil. *It is used in erectile dysfunction* - This statement is correct. **Tadalafil** (Cialis®) is widely prescribed for the treatment of **erectile dysfunction (ED)** due to its ability to improve erectile function. - It enhances the effects of nitric oxide, leading to relaxation of penile smooth muscle and increased blood flow necessary for an erection. *Its half life is 17.5 hours* - This statement is correct. The relatively **long half-life of 17.5 hours** is a key pharmacological feature of tadalafil contributing to its prolonged duration of action. - This extended half-life allows for once-daily dosing in some indications and a longer therapeutic window for on-demand use.
Question 4: Which of the following is not a recognized use of alpha-2-agonists?
- A. Glaucoma
- B. Hypertension
- C. Sedation
- D. Benign Hyperplasia of prostate (Correct Answer)
Explanation: ***Correct Answer: Benign Hyperplasia of prostate*** - Alpha-2-agonists are **NOT** used to treat **benign prostatic hyperplasia (BPH)**; this condition is typically managed with **alpha-1-blockers** (e.g., tamsulosin, alfuzosin) or 5-alpha-reductase inhibitors. - Alpha-1-blockers relax the smooth muscle in the prostate and bladder neck, improving urine flow, which involves a different receptor mechanism than alpha-2-agonists. - Alpha-2-agonists would not provide therapeutic benefit for BPH. *Incorrect: Glaucoma* - Alpha-2-agonists (e.g., **brimonidine**, **apraclonidine**) **are** used to treat **glaucoma** by reducing aqueous humor production and increasing uveoscleral outflow. - This action helps to **lower intraocular pressure**, a primary goal in glaucoma management. *Incorrect: Hypertension* - Central-acting alpha-2-agonists (e.g., **clonidine**, **methyldopa**) **are** used as **antihypertensive agents**. - They reduce sympathetic outflow from the central nervous system, leading to decreased heart rate, vasodilation, and consequently, **lower blood pressure**. *Incorrect: Sedation* - Alpha-2-agonists like **dexmedetomidine** and **clonidine** **are** commonly used for **sedation** in critically ill patients, especially in intensive care units. - They produce sedation, analgesia, and anxiolysis without causing significant respiratory depression, making them valuable in certain clinical settings.
Question 5: Which class of antihypertensive drugs is known to cause erectile dysfunction?
- A. Calcium channel blocker
- B. ACE inhibitors
- C. AT1 receptor antagonists
- D. Beta-blockers (Correct Answer)
Explanation: ***Beta-blockers*** - **Beta-blockers** are the antihypertensive class most commonly associated with **erectile dysfunction** - Mechanism: Reduced cardiac output, decreased peripheral blood flow, central nervous system effects reducing libido, and blockade of β2-mediated vasodilation - **Non-selective beta-blockers** (propranolol, nadolol) have higher incidence of ED compared to selective β1-blockers (metoprolol, atenolol) - Newer vasodilating beta-blockers (nebivolol, carvedilol) have lower risk of sexual dysfunction *Calcium channel blockers* - Generally have **neutral or minimal effect** on erectile function - May even improve ED in some patients due to **vasodilatory properties** - Side effects include peripheral edema and headache, but not sexual dysfunction *ACE inhibitors* - Associated with **lower risk of erectile dysfunction** compared to other antihypertensives - May have neutral or even protective effects on sexual function - Preferred choice for hypertensive patients with existing sexual dysfunction concerns - Common side effects: dry cough and angioedema (not related to sexual function) *AT1 receptor antagonists* - **ARBs have neutral to potentially beneficial effects** on sexual function - Considered an excellent alternative for patients experiencing sexual side effects with other antihypertensive medications - Some studies suggest they may improve erectile function in hypertensive patients
Question 6: Which of the following is the best inotrope agent for use in right heart failure secondary to pulmonary hypertension?
- A. Milrinone (Correct Answer)
- B. Dobutamine
- C. Digoxin
- D. Dopamine
Explanation: ***Milrinone*** - Milrinone is a **phosphodiesterase-3 inhibitor** that increases myocardial contractility and causes **pulmonary and systemic vasodilation**. - Its vasodilatory effect is particularly beneficial in **pulmonary hypertension** as it can help reduce **pulmonary vascular resistance (PVR)**, a critical factor in right heart failure. - The combination of **positive inotropy** and **selective pulmonary vasodilation** makes it the optimal choice for right ventricular failure secondary to pulmonary hypertension. *Dobutamine* - Dobutamine is a **beta-1 agonist** that primarily increases myocardial contractility with some beta-2 mediated vasodilation. - While it improves cardiac output, its lesser effect on **pulmonary vascular resistance** compared to milrinone makes it less ideal for right heart failure specifically complicated by pulmonary hypertension. *Digoxin* - Digoxin is a **cardiac glycoside** that increases contractility but has a slow onset of action and a narrow therapeutic window, making it less suitable for acute management. - It does not significantly reduce **pulmonary vascular resistance** and is primarily used for chronic heart failure or rate control in atrial fibrillation. *Dopamine* - Dopamine is a **catecholamine** with dose-dependent effects: at moderate doses (5-10 mcg/kg/min), it acts as a **beta-1 agonist** providing inotropic support. - However, at higher doses it causes **alpha-adrenergic vasoconstriction** which can **increase pulmonary vascular resistance**, potentially worsening right heart failure in pulmonary hypertension. - Unlike milrinone, it lacks specific pulmonary vasodilatory properties beneficial for reducing RV afterload.
Question 7: Which of the following medications is not typically used for the treatment of erectile dysfunction?
- A. Beta blockers (Correct Answer)
- B. Papaverine
- C. Sildenafil
- D. PG-E
Explanation: ***Beta blockers*** - **Beta blockers** are primarily used to treat conditions like **hypertension** and **heart disease**. - While they can cause ED as a side effect, they are **not used for its treatment**. *Sildenafil* - **Sildenafil** is a **PDE5 inhibitor** that works by increasing **blood flow to the penis**, facilitating an erection. - It is a **first-line oral medication** widely prescribed for erectile dysfunction. *PG-E* - **PG-E** refers to **Prostaglandin E1** (alprostadil), which can be administered via **intracavernosal injection** or **urethral suppository**. - It directly causes **vasodilation** in the penis, leading to an erection, and is used when oral medications are ineffective or contraindicated. *Papaverine* - **Papaverine** is a **non-specific vasodilator** that can be used as an **intracavernosal injection** for ED. - It works by relaxing **smooth muscle** in the penile arteries, increasing blood flow and inducing an erection, often used in combination with phentolamine.
Question 8: Drug of choice for Liddle syndrome
- A. Furosemide
- B. Amiloride (Correct Answer)
- C. Spironolactone
- D. Acetazolamide
Explanation: ***Amiloride*** - **Amiloride** is a potassium-sparing diuretic that directly blocks the **epithelial sodium channel (ENaC)** in the collecting duct. - Liddle syndrome is caused by a gain-of-function mutation in ENaC, leading to excessive sodium reabsorption and potassium excretion, which **amiloride directly counters**. - This makes it the **specific and most effective treatment** for this genetic condition. *Furosemide* - **Furosemide** is a loop diuretic that blocks the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle. - While it can induce diuresis, it does not specifically target the **ENaC overactivity** seen in Liddle syndrome, making it less effective. *Spironolactone* - **Spironolactone** is an aldosterone antagonist that blocks the mineralocorticoid receptor. - Liddle syndrome involves a **defect in ENaC function directly**, not excess aldosterone, so spironolactone is generally ineffective. *Acetazolamide* - **Acetazolamide** is a carbonic anhydrase inhibitor that acts primarily in the proximal tubule to reduce bicarbonate reabsorption. - Its mechanism of action is unrelated to the **excessive ENaC activity** characteristic of Liddle syndrome.
Question 9: A female has a systolic blood pressure of 130 mmHg and a diastolic blood pressure of 100 mmHg on two consecutive occasions, indicating Stage 2 hypertension. What is the best treatment?
- A. Rest
- B. Sedative
- C. Error in BP Machine
- D. Anti-hypertensive drugs (Correct Answer)
Explanation: ***Anti-hypertensive drugs*** - A blood pressure of 130/100 mmHg on two consecutive occasions confirms **Stage 2 hypertension**, necessitating pharmacological intervention. [1] - Due to the elevated **diastolic blood pressure**, medication is required to prevent target organ damage and cardiovascular events. [1] *Rest* - While rest can temporarily lower blood pressure, it is insufficient to manage **chronic hypertension** at this stage. [1] - It does not address the underlying physiological dysregulation causing the sustained elevated pressure. *Sedative* - Sedatives might acutely lower blood pressure by reducing anxiety but are not a primary treatment for **hypertension**. - They do not provide long-term control and can have significant side effects. *Error in BP Machine* - While a machine error is always a possibility, repeating the measurement on **two separate occasions** makes a systemic error less likely. - Relying solely on the possibility of an error without further investigation and management of the presented values is irresponsible.
Question 10: A 27-year-old intravenous drug user presents with difficulty swallowing. Examination of the oropharynx reveals white plaques along the tongue and the oral mucosa. Which of the following best describes the microscopic appearance of the microorganism responsible for this patient's illness?
- A. Budding yeast and pseudohyphae (Correct Answer)
- B. Encapsulated yeast
- C. Mold with nonseptate hyphae
- D. Mold with septate hyphae
Explanation: ***Budding yeast and pseudohyphae*** - The clinical presentation of **white plaques** in the oropharynx of an **IV drug user** strongly suggests **oral candidiasis** (thrush), caused by *Candida albicans*. - Microscopically, *Candida albicans* is characterized by **budding yeast** forms and the formation of **pseudohyphae** when invading tissues. *Encapsulated yeast* - This description typically refers to *Cryptococcus neoformans*, which is known for its **thick polysaccharide capsule**. - While *Cryptococcus* can cause infections in immunocompromised individuals, it typically presents with **meningitis** or **pulmonary disease**, not oral thrush. *Mold with nonseptate hyphae* - This morphology is characteristic of organisms causing **zygomycosis** (e.g., *Rhizopus*, *Mucor*). - These infections usually present as **rhinocerebral** or **pulmonary involvement** and are not associated with superficial oral plaques like those seen in this patient. *Mold with septate hyphae* - This describes many common molds, including *Aspergillus* species, which typically cause **invasive pulmonary disease**, **sinusitis**, or **allergic bronchopulmonary aspergillosis**. - These organisms are **not typically associated** with oral thrush and produce true hyphae with septations, unlike the pseudohyphae of *Candida*.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free